A Programmable Peptidic Hydrogel Adjuvant for Personalized Immunotherapy in Resected Stage Tumors

Investigators described a programmable hydrogel adjuvant for personalized immunotherapy after surgical resection. By filling the hydrogel in the cavity, this system addressed the limited secretion of granzyme B during immunotherapy and improve the low immunotherapy responses typically observed.